UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000019863
Receipt No. R000022935
Scientific Title Prospective study for evaluating coronary microvascular dysfunction in patients with vasospastic angina
Date of disclosure of the study information 2015/11/24
Last modified on 2017/11/21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prospective study for evaluating coronary microvascular dysfunction in patients with vasospastic angina
Acronym Prospective study for evaluating coronary microvascular dysfunction in patients with vasospastic angina
Scientific Title Prospective study for evaluating coronary microvascular dysfunction in patients with vasospastic angina
Scientific Title:Acronym Prospective study for evaluating coronary microvascular dysfunction in patients with vasospastic angina
Region
Japan

Condition
Condition vasospastic angina
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 evaluating microvascular dysfunction in patients with vasospastic angina
Basic objectives2 Others
Basic objectives -Others physiological assessment
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comparison of the index of microcirculatory resistance (IMR) between patients with positive acetylcholine (ACh) provocation test and those with negative
Key secondary outcomes 1) Coronary flow reserve (CFR) in patients with positive or negative ACh provocation test
2) Relation between chest symptom and IMR or CFR
3) Relation between IMR or CFR and chest symptom in patients with negative ACh provocation test
4) IMR, CFR and mean transit time (MTT) which indicate coronary epicardial or microvascular spasm
5) Relation between reactive hyperemia index (RHI) and IMR, CFR, MTT, or positivity of ACh provocation test
6) Relation between RHI and chest symptom

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 Evaluation for coronary microvascular dysfunction with Certus Pressure Wire during ACh provocation test
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria 1) Patients who planned to undergo ACh provocation test
2) Patients who discontinue coronary dilator >48 hours before ACh provocation test
Key exclusion criteria 1) Patients with hemodialysis
2) Patients with severe hepatic disorder
3) Patients with severe heart failure (ejection fraction <30% or NYHA >class 3)
4) Patients with prior coronary intervention for left anterior descending artery
Target sample size 40

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Yoshio Kobayashi
Organization Chiba University Hospital
Division name Department of Cardiovascular Medicine
Zip code
Address 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
TEL 043-222-7171
Email tsuchiya-chiba@umin.ac.jp

Public contact
1st name of contact person
1st name
Middle name
Last name Yuichi Saito
Organization Chiba University Hospital
Division name Department of Cardiovascular Medicine
Zip code
Address 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
TEL 043-222-7171
Homepage URL
Email policemaccho@yahoo.co.jp

Sponsor
Institute Chiba University Hospital, Department of Cardiovascular Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2015 Year 11 Month 19 Day
Date of IRB
Anticipated trial start date
2015 Year 11 Month 24 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 11 Month 19 Day
Last modified on
2017 Year 11 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022935

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.